tiprankstipranks
Resmed (RMD)
NYSE:RMD
US Market
Want to see RMD full AI Analyst Report?

Resmed (RMD) Financial Statements

1,200 Followers

Resmed Financial Overview

Resmed's market cap is currently $32.38B. The company's EPS TTM is $10.44; its P/E ratio is 21.50; and it has a dividend yield of 1.23%. Resmed is scheduled to report earnings on August 6, 2026, and the estimated EPS forecast is $2.69. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total Revenue$ 5.65B$ 5.15B$ 4.69B$ 4.22B$ 3.58B
Gross Profit$ 3.46B$ 3.05B$ 2.66B$ 2.36B$ 2.02B
Operating Income$ 1.89B$ 1.69B$ 1.32B$ 1.13B$ 1.00B
EBITDA$ 2.15B$ 1.91B$ 1.53B$ 1.36B$ 1.18B
Net Income$ 1.52B$ 1.40B$ 1.02B$ 897.56M$ 779.44M
Balance Sheet
Cash & Short-Term Investments$ 1.47B$ 1.21B$ 238.36M$ 227.89M$ 273.71M
Total Assets$ 8.97B$ 8.17B$ 6.87B$ 6.75B$ 5.10B
Total Debt$ 825.92M$ 851.81M$ 873.93M$ 1.58B$ 917.55M
Net Debt$ -643.32M$ -357.64M$ 635.57M$ 1.35B$ 643.84M
Total Liabilities$ 2.38B$ 2.21B$ 2.01B$ 2.62B$ 1.74B
Stockholders' Equity$ 6.59B$ 5.97B$ 4.86B$ 4.13B$ 3.36B
Cash Flow
Free Cash Flow$ 1.65B$ 1.66B$ 1.29B$ 559.30M$ 195.11M
Operating Cash Flow$ 1.81B$ 1.75B$ 1.40B$ 693.30M$ 351.15M
Investing Cash Flow$ -545.20M$ -200.04M$ -269.78M$ -1.16B$ -229.92M
Financing Cash Flow$ -1.01B$ -606.25M$ -1.12B$ 422.87M$ -128.36M
Currency in USD

Resmed Earnings and Revenue History

Resmed Debt to Assets

Resmed Cash Flow

Resmed Forecast EPS vs Actual EPS